SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
MD

Pediatrix Medical Group, Inc. (New York Stock Exchange:MD)

US · Delayed Price · Currency is USD
Healthcare · Medical - Care Facilities
29.02-0.28 (-0.94%)
 
Market cap
$2.36B
Health Score
Analyst consensus
Listed since
Sep 20, 1995
Insider Score
––Not scored
MD Insider Score

Insiders here have filed 8 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.

MD Stock Insider Trading Activity

MD stock’s insider trading shows 1 sale on the open market for an estimated $855.66K by company insiders over the last 6 months.

Not enough price history.

Insider Trading Activity (Form 4 Filings)

An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.

InsiderActionSharesAvg CostTotalΔ HoldingsHeld AfterDateGradeForm 4
Starcher John M. Jr.
Director
Award472$26.50$12.51K 0.6%73,732Aug 12, 2026— Form 4
Rucker Michael A.
Director
Award472$26.50$12.51K 0.7%66,769Aug 12, 2026— Form 4
Young Sylvia Jean
Director
Award472$26.50$12.51K 1.0%48,286Aug 12, 2026— Form 4
McEachin Thomas
Director
Award472$26.50$12.51K 6.6%7,668Aug 12, 2026— Form 4
SANSONE GUY P
Director
Award472$26.50$12.51K 0.5%87,416Aug 12, 2026— Form 4
Weis Shirley A
Director
Award472$26.50$12.51K 2.5%19,095Aug 12, 2026— Form 4
Newman Kurt Douglas
Director
Award472$26.50$12.51K 2.8%17,405Aug 12, 2026— Form 4
Linynsky Laura A
Director
Award472$26.50$12.51K 1.2%39,900Aug 12, 2026— Form 4
Haddock David
Other
Award20,036—— New20,036Jun 22, 2026— Form 4
Moore Mary Ann E
Other
Gift18,407—— 19.7%111,831Jun 9, 2026— Form 4
Moore Mary Ann E
Other
Gift18,407—— 19.1%78,059Jun 9, 2026— Form 4
ORDAN MARK S
CEO
To issuer97,174—— 23.6%313,710Jun 2, 2026— Form 4
ORDAN MARK S
CEO
Award97,174—— 31.0%410,884Jun 2, 2026— Form 4
Moore Mary Ann E
Other
Tax withheld11,944$21.54$257.27K 11.0%96,466Jun 1, 2026— Form 4
Rossi Kasandra H
CFO
Tax withheld3,701$21.54$79.72K 3.5%101,399Jun 1, 2026— Form 4
Rossi Kasandra H
CFO
Award31,800—— 43.4%105,100Jun 1, 2026— Form 4
ORDAN MARK S
CEO
Tax withheld19,119$21.54$411.82K 4.4%410,884Jun 1, 2026— Form 4
ORDAN MARK S
CEO
Award127,198—— 42.0%430,003Jun 1, 2026— Form 4
Neeb Don Gregory
Other
Award63,888—— 78.5%145,234Jun 1, 2026— Form 4
Neeb Don Gregory
Other
Tax withheld8,003$21.54$172.38K 5.5%137,231Jun 1, 2026— Form 4
McEachin Thomas
Director
Gift11,427—— 20.9%66,073May 13, 2026— Form 4
Weis Shirley A
Director
Sell36,028$23.75$855.66K 100%0May 13, 2026— Form 4
McEachin Thomas
Director
Gift11,427—— 61.4%7,196May 13, 2026— Form 4
Moore Mary Ann E
Other
Gift40,826—— 27.4%108,410May 11, 2026— Form 4
Young Sylvia Jean
Director
Award7,196—— 17.7%47,814May 7, 2026— Form 4
Starcher John M. Jr.
Director
Award7,196—— 10.9%73,260May 7, 2026— Form 4
McEachin Thomas
Director
Award7,196—— 63.0%18,623May 7, 2026— Form 4
Newman Kurt Douglas
Director
Award7,196—— 73.9%16,933May 7, 2026— Form 4
Weis Shirley A
Director
Award7,196—— 63.0%18,623May 7, 2026— Form 4
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
  • Sell (S) — Open-market or private sale
  • Award (A) — Grant or award from the company, not a purchase
  • To issuer (D) — Shares returned or sold back to the company
  • Tax withheld (F) — Shares withheld to pay tax or an exercise price
  • Gift (G) — Bona fide gift
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.